Lucintel’s latest market report analyzed that interventional cardiology and peripheral vascular device provides attractive opportunities in hospitals and ambulatory surgical centers. The interventional cardiology and peripheral vascular device market is expected to reach $31.6 billion by 2027 with a CAGR of 5.7%. In this market, interventional cardiology devices is the largest segment by type, whereas hospitals is largest by end user. Rising adoption of TAVR procedure, increasing use of bioresorbable stents, and rising adoption of drug eluting balloons provides strategic growth path in this market.
Download Brochure of this report by clicking on https://www.lucintel.com/interventional-cardiology-peripheral-vascular-devi.aspx Based on type, the interventional cardiology and peripheral vascular device market is segmented into interventional cardiology and peripheral vascular device. The interventional cardiology devices segment accounted for the largest share of the market in 2021 and is expected to register the highest CAGR during the forecast period.
Browse in-depth TOC on “Interventional Cardiology and Peripheral Vascular Device Market”
97 – Tables
112 – Figures
201 – Pages
The Interventional Cardiology and Peripheral Vascular Device Market is marked by the presence of several big and small players. Some of the prominent players offering interventional cardiology and peripheral vascular device include Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences Corporation, Medtronics Public Limited Company, C. R. Bard, Inc., Cook Medical Inc., Terumo Corporation, and Cardinal Health Inc.
Request Sample Report:
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link email@example.com.
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.
Company Name: Lucintel
Contact Person: Brandon Fitzgerald
Email: Send Email
Address:8951 Cypress Waters Blvd., Suite 160
Country: United States